Academic Cardiovascular Program at Hackensack University Medical Center Fosters Translational Breakthroughs

Training next generation of clinicians prioritized along with robust research study

The academic arm of Hackensack University Medical Center’s Cardiovascular Program emphasizes education and translational medical research, bringing breakthroughs to the bedside.

Currently, the Heart and Vascular Hospital team is participating in more than 80 clinical research trials. Over the past two years, staff have presented more than 300 scientific papers at national and international cardiovascular meetings and published field-shifting results in more than 250 publications.

Researchers are engaged in diverse study areas, including:

• Door to Unloading Trial, evaluating the role of p-VAD prior to opening an obstructed coronary artery for acute heart attack
• Tendyne nonsurgical mitral valve replacement
• New temporary ventricular assist devices, including the Impella 5.5®
• Renal artery ablation addressing hypertension and atrial fibrillation
• Effectiveness of blood transfusions during heart attack
• Early diagnostic test development for diagnosis and treatment for septic shock
• Real-world research database study of shock, critically ill cardiovascular patients, serious arrhythmias and cardiac problems in COVID-19 patients

In addition to an extensive research arm, academic priorities also include cardiovascular physician training. The program offers highly competitive fellowship opportunities in general cardiology, structural heart disease, interventional cardiology and advanced heart failure. The center’s approaches to critical care are shared with medical trainees globally through the best-selling 5th Edition of the standard medical textbook Critical Care Medicine: Principles of Diagnosis and Management in the Adult, which was edited by Heart and Vascular Hospital chairman Joseph E. Parrillo, M.D., with contributions from 16 Hackensack University Medical Center physicians.